Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Experimental Hematology ; (6): 698-701, 2016.
Artigo em Chinês | WPRIM | ID: wpr-360024

RESUMO

<p><b>OBJECTIVE</b>To study the curative effect of HAG and CAG regimens for patients with acute myelocytic leukemia (AML) and high/medium-risk myelodysplastic syndrome (MDS).</p><p><b>METHODS</b>Fifty two patients from January 2010 to January 2014 were enrolled in this study, 32 were diagnosed with AML and 20 with MDS. All the patients were divided into 2 groups: 26 in HAG group (26 cases) and another 26 in CAG group (26 cases). The bone marrow examination, remission rate, PFS, OS and side reaction rates were compared between 2 groups.</p><p><b>RESULTS</b>After treatment, the bone marrow hyperplasia and juvenile cells were decreased significantly. In HAG group, the remission rate was 57.69% and that was 76.92% in CAG group, the difference between these 2 groups was statistically significant (P<0.05), but the survival time was not statistically significant different between 2 groups (P>0.05). The incidence of side reaction in HAG group was 11.54%, that in CAG group was 7.69%, there was no statistically significant difference (P>0.05).</p><p><b>CONCLUSION</b>Both CAG and HAG regimens have shown significant curative effects for acute myelocytic leukemia and high/medium-risk myelodysplastic syndrome.</p>


Assuntos
Humanos , Aclarubicina , Usos Terapêuticos , Protocolos de Quimioterapia Combinada Antineoplásica , Usos Terapêuticos , Exame de Medula Óssea , Citarabina , Usos Terapêuticos , Fator Estimulador de Colônias de Granulócitos , Usos Terapêuticos , Leucemia Mieloide Aguda , Tratamento Farmacológico , Síndromes Mielodisplásicas , Tratamento Farmacológico , Indução de Remissão
2.
China Journal of Chinese Materia Medica ; (24): 2102-2105, 2014.
Artigo em Chinês | WPRIM | ID: wpr-299822

RESUMO

To study the effects of alkaloids from Coptidis Rhizoma on low-density lipoprotein receptor (LDLR) mRNA expression and antihyperlipedemic levels. The LDLR mRNA expression were detected by real time fluorescence quantitative PCR, and the levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL-c) and high-density lipoprotein cholesterol (HDL-c) in serum were measured at the first and last examination. The results show that, after the drug treatment, compared with the model group, each drug group showed a lipid-lowering effect. Especially, coptisine, palmatine, jatrorrhinze were significantly reduced TC, TG, LDL-c (P < 0.05, P < 0.01), and increased HDL-c (P < 0.01). In addition, they also increased mRNA expression of the LDLR in liver and HepG2 cells. The results showed that alkaloids from Coptidis Rhizoma can regulate lipid metabolism disorder, and coptisine have the best lipid-lowering effect.


Assuntos
Animais , Cricetinae , Humanos , Alcaloides , Colesterol , Metabolismo , Medicamentos de Ervas Chinesas , Hiperlipidemias , Tratamento Farmacológico , Genética , Metabolismo , Hipoglicemiantes , Metabolismo dos Lipídeos , Lipídeos , Sangue , Lipoproteínas LDL , Metabolismo , Mesocricetus , Receptores de Lipoproteínas , Genética , Metabolismo , Triglicerídeos , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA